Drug Side Effects
Search
APHERESIS
APHERESIS
was reported 50 times
APHERESIS is most prevalent among patients taking these drug classes:
#
Drug class
Count
Frequency
0
CD38-directed Cytolytic Antibody [EPC]
7
0.0012
1
Lymphocyte Growth Factor [EPC]
1
0.0008
2
Interleukin-17 Receptor A Antagonist [EPC]
1
0.0005
3
PCSK9 Inhibitor [EPC]
7
0.0003
4
Complement Inhibitor [EPC]
7
0.0001
5
Topoisomerase Inhibitor [EPC]
7
0.0001
6
Hemoglobin S Polymerization Inhibitor [EPC]
2
0.0001
7
Proteasome Inhibitor [EPC]
7
0.0001
8
Alkylating Drug [EPC]
11
0.0000
9
Penem Antibacterial [EPC]
1
0.0000
10
Leukocyte Growth Factor [EPC]
4
0.0000
11
Platinum-based Drug [EPC]
7
0.0000
12
Dihydrofolate Reductase Inhibitor Antibacterial [EPC]
2
0.0000
13
Thalidomide Analog [EPC]
10
0.0000
14
BCL-2 Inhibitor [EPC]
1
0.0000
15
Glycopeptide Antibacterial [EPC]
1
0.0000
16
Potassium Channel Blocker [EPC]
1
0.0000
17
Dietary Cholesterol Absorption Inhibitor [EPC]
1
0.0000
18
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
0.0000
19
5-alpha Reductase Inhibitor [EPC]
1
0.0000
20
Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
21
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]
1
0.0000
22
Corticosteroid [EPC]
10
0.0000
23
Prostacycline Vasodilator [EPC]
1
0.0000
24
Azole Antifungal [EPC]
1
0.0000
25
Kinase Inhibitor [EPC]
2
0.0000
26
CD20-directed Cytolytic Antibody [EPC]
1
0.0000
27
Angiotensin 2 Receptor Blocker [EPC]
1
0.0000
28
HMG-CoA Reductase Inhibitor [EPC]
1
0.0000
29
Folate Analog Metabolic Inhibitor [EPC]
1
0.0000
30
Tumor Necrosis Factor Blocker [EPC]
2
0.0000